Aptinyx Inc. (APTX) financial statements (2022 and earlier)

Company profile

Business Address 1801 MAPLE AVENUE
EVANSTON, IL 60201
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments106,124141,02898,849150,637
Cash and cash equivalents106,124141,02898,849150,637
Restricted cash and investments197179179252
Receivables 257444578
Prepaid expense1,1221,177994673
Other undisclosed current assets7,3006,9634,6431,111
Total current assets:114,743149,604105,109153,251
Noncurrent Assets
Property, plant and equipment1859101,2041,690
Other noncurrent assets 92166673
Total noncurrent assets:1851,0021,3702,363
TOTAL ASSETS:114,928150,606106,479155,614
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,1893,2483,4803,932
Accounts payable6221,2091,5551,889
Employee-related liabilities2,5672,0391,9252,043
Other undisclosed current liabilities2,4971,3351,4161,953
Total current liabilities:5,6864,5834,8965,885
Noncurrent Liabilities
Long-term debt and lease obligation14,155   
Long-term debt, excluding current maturities14,155   
Liabilities, other than long-term debt331114272418
Other liabilities331114272418
Total noncurrent liabilities:14,486114272418
Total liabilities:20,1724,6975,1686,303
Stockholders' equity
Stockholders' equity attributable to parent94,756145,909101,311149,311
Common stock677633337333
Additional paid in capital381,966358,277263,922254,516
Accumulated deficit(287,887)(213,001)(162,948)(105,538)
Total stockholders' equity:94,756145,909101,311149,311
TOTAL LIABILITIES AND EQUITY:114,928150,606106,479155,614

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues1,0001,5643,6696,574
Gross profit:1,0001,5643,6696,574
Operating expenses(75,534)(52,329)(63,282)(61,462)
Operating loss:(74,534)(50,765)(59,613)(54,888)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(352)7122,2031,607
Net loss available to common stockholders, diluted:(74,886)(50,053)(57,410)(53,281)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(74,886)(50,053)(57,410)(53,281)
Comprehensive loss, net of tax, attributable to parent:(74,886)(50,053)(57,410)(53,281)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: